Engel, Julia
Wieder, Vanessa
Bauer, Marcus
Kaufhold, Sandy
Stückrath, Kathrin
Wilke, Jochen
Hanf, Volker
Uleer, Christoph
Lantzsch, Tilmann
Peschel, Susanne
John, Jutta
Pöhler, Marleen
Weigert, Edith
Bürrig, Karl-Friedrich
Buchmann, Jörg
Santos, Pablo
Kantelhardt, Eva Johanna
Thomssen, Christoph
Vetter, Martina
Funding for this research was provided by:
Martin-Luther-Universität Halle-Wittenberg
Article History
Received: 26 February 2024
Accepted: 22 July 2024
First Online: 17 August 2024
Change Date: 14 November 2024
Change Type: Update
Change Details: The original online version of this article was revised to correct the typo in first paragraph of Results section.
Change Date: 20 November 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10549-024-07520-6
Declarations
:
: C.T. resports support from Amgen, AstraZeneca, Aurikamed, Daichi-Synkyo, Forum Sanitas, Gilead, Jörg Eickeler, Hexal, Lilly, Medupdate, MSD, Nanostring, Novartis, Onkowissen, Pfizer, Roche, Seagen, Vifor. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. All other authors have no relevant financial or non-financial interests to disclose.
: The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of the Medical Faculty of the Martin Luther University Halle-Wittenberg (#214/16.12.09/11).
: Informed consent was obtained from all subjects involved in the study.